Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History


Sector: Healthcare | Sub-Sector: Diagnostics & Research
Alternate Symbol(s): MBGNF

Med BioGene Inc. is a life science company focused on the development and commercialization of genomic-based clinical laboratory diagnostic tests.
Price: $0.075 | Change: $0.00 | % Change: 0.00%
Volume: 0 | Day High/Low: N/A/N/A | 52 Week High/Low: 0.21/0.07


Last Traded: April 21, 2014 07:39 Transaction Volume: 0
Open: $0.075 Previous Close: $0.075
Bid: $0.07 Ask: $0.08
Bid Size: 164,000 Ask Size: 65,000
Market Cap: $5.8m Shares Out: 77.6m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts


Is Med Biogene (V.MBI) poised for a breakout?

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   January 13, 2014
0 stars

Stockhouse Research: Habanero jumps, Blackberry drops, Fission hangs

The best of our bullboards, blogs, stories and groups for August 30, 2013.

Chris Parry   August 30, 2013
0 stars

Latest Bullboard Posts

  • RE:RE:I`m getting antsy

    0 stars

    Too late ...that ship has sailed already.

    2.5 stars

  • RE:I`m getting antsy

    0 stars

    either that or Broshko is having difficulty with the wordings of the nr, like should I still mention the launch again without any...

    3 stars

  • I`m getting antsy

    0 stars

    Where the heck is the Annual Report? I`m thinking the accountants don`t like the way the CFO has fudged the numbers and the two sides are...

    4.5 stars

  • Pharma Deals

    1 star

    going on left and right...while MBI makes new 52 week lows and continues to loss share value week after week.

    2.5 stars

  • Almac News

    0 stars

    April 15, 2014 Almac Receives New York State Laboratory Permit for Trial Enrichment and Companion Diagnostics Development...

    4 stars